Hasbani Follows Up The Death Of Farah Kassab And Issues Two Decisions And Two Letters To The General

Hasbani Follows up the Death of Farah Kassab and Issues Two Decisions and Two Letters to the General Prosecution and the Order of Physicians

The Information Office of Deputy Prime Minister Health Minister Ghassan Hasbani issued the following statement:

In the context of following up the death of Farah Kassab after she underwent a cosmetic surgery in a specialized hospital in cosmetic surgeries,

Health Minister Ghassan Hasbani took the following actions:

The issuance of a decision on the prevention of surgical operations that require a general anesthetic in day hospitals or other cosmetic surgery clinics.
The issuance of a decision on the prevention of surgical operations that require a general anesthetic in Dr. Nader Saab hospital specialized in cosmetic surgery.
The issuance of a letter to the Public Prosecutor to investigate into the death of Farah Kassab.
The issuance of a letter to the Lebanese Order of Physicians in Beirut to conduct necessary investigations into the death of Farah Kassab, and give the Order a period of two weeks to clarify some technical medical points and answer questions asked by Health Minister concerning the death of the said woman.

These steps came to complete the immediate oral decision of Health Minister Ghassan Hasbani to cease operations in the said clinic after the woman's death, and the written decision issued Friday 2 June 2017 which stipulates the following:

Surgeries that may cause complications that require intensive care like liposuction and other surgeries shall not performed in places other than specialized hospitals which include an intensive care division that holds a license form Health Ministry in accordance with due process.
The doctor should explain to the patient the risks of the surgery, including the plastic surgery, and ask the patient to sign the Patient Right Form and the informed consent.

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R03DC03	MONTELUKAST ARROW LAB	G	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	851,996 L.L
R03DC03	MONTELUKAST-SANDOZ	G	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	1,184,140 L.L
R05CA03	MUCINEX	G	Guaifenesin - 600mg	600mg	Tablet, extended release	749,864 L.L
R05CB03	MUCOTAL PEDIATRIQUE	G	Carbocysteine - 100mg/5ml	100mg/5ml	Syrup	298,205 L.L
R05CB03	MUCOTAL ADULTE	G	Carbocysteine - 250mg/5ml	250mg/5ml	Syrup	308,444 L.L
R05CB06	MUCUM	G	Ambroxol HCl - 15mg/5ml	15mg/5ml	Syrup, sugar free, alcohol free	98,101 L.L
R05CB06	MUCOSOLVAN	B	Ambroxol HCl - 30mg/5ml	30mg/5ml	Syrup	380,307 L.L
R05CB06	MUCOVIC FORTE	G	Ambroxol HCl - 30mg/5ml	30mg/5ml	Solution, sugar free	293,086 L.L
R05CB06	MUCOVIC FORTE	G	Ambroxol HCl - 30mg/5ml	30mg/5ml	Solution, sugar free	440,268 L.L
R05CB06	MUKORAL	G	Ambroxol HCl - 30mg/5ml	30mg/5ml	Syrup	341,336 L.L
R05CB06	MUKORAL	G	Ambroxol - 30mg	30mg	Tablet	201,576 L.L
R05CB06	MUCOSOLVAN LA	B	Ambroxol HCl - 75mg	75mg	Capsule	345,368 L.L
R05FB02	MUCUS RELIEF DM	G	Dextromethorphan HBr - 20mg, Guaifenesin - 400mg		Tablet	413,903 L.L
R05X	MUCOTAL PROMETHAZINE	G	Promethazine HCl - 2.5mg/5ml, Carbocysteine - 100mg/5ml		Syrup	243,172 L.L
R06AA52	MENTEX	G	Diphenhydramine HCl - 12.5mg/5ml, Dextrometorphan HBr - 15mg/5ml, Pseudoephedrine HCl - 30mg/5ml		Syrup	323,866 L.L
S01AE07	MOXITEC	G	Moxifloxacin (HCl) - 5mg/ml	5mg/ml	Drops solution	464,970 L.L
S01EB02	MIOSTAT STERIL INTRAOCULAR	B	Carbachol - 0.01%	0.01%	Solution	8,117,591 L.L
S01EB09	MIOVISIN	G	Acetylcholine chloride - 20mg/2ml	20mg/2ml	Injectable powder for solution+solvent	6,449,100 L.L
S01EE01	MONOPROST	G	Latanoprost - 50mcg/ml	50mcg/ml	Drops solution	1,187,957 L.L
S01FA06	MYDRIACYL	B	Tropicamide - 1%	1%	Drops solution	430,030 L.L
S03CA04	MYCICORT	G	Hydrocortisone acetate - 5mg, Neomycin sulfate - 5mg		Drops suspension	166,381 L.L

...